Information de reference pour ce titreAccession Number: | 00005650-202002000-00002.
|
Author: | Geissler, Kimberley H. PhD; Evans, Elizabeth A. PhD
|
Institution: | Department of Health Promotion and Policy, School of Public Health and Health Sciences, University of Massachusetts Amherst, Amherst, MA
|
Title: | |
Source: | Medical Care. 58(2):101-107, February 2020.
|
Abstract: | Background: Adequate access for mental illness and substance use disorder (SUD) treatment, particularly for Medicaid enrollees, is challenging. Policy efforts, including the Mental Health Parity and Addiction Equity Act (MHPAEA), have targeted expanded access to care. With MHPAEA, more Medicaid plans were required to increase their coverage of SUD treatment, which may impact provider acceptance of Medicaid.
Objectives: To identify changes in Medicaid acceptance by SUD treatment facilities after the implementation of MHPAEA (parity).
Research Design: Observational study using an interrupted time series design.
Subjects: 2002-2013 data from the National Survey of Substance Abuse Treatment Services (N-SSATS) for all SUD treatment facilities was combined with state-level characteristics.
Measures: Primary outcome is whether a SUD treatment facility reported accepting Medicaid insurance.
Results: Implementation of MHPAEA was associated with a 4.6 percentage point increase in the probability of an SUD treatment facility accepting Medicaid (P<0.001), independent of facility and state characteristics, time trends, and key characteristics of state Medicaid programs.
Conclusions: After parity, more SUD treatment facilities accepted Medicaid payments, which may ultimately increase access to care for individuals with SUD. The findings underscore how parity laws are critical policy tools for creating contexts that enable historically vulnerable and underserved populations with SUD to access needed health care.
Copyright (C) 2020 Wolters Kluwer Health, Inc. All rights reserved.
|
Author Keywords: | Medicaid; parity; substance use disorder treatment; access to care.
|
References: | 1. Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results From the 2016 National Survey on Drug Use and Health (HHS Publication No SMA 17-5044, NSDUH Series H-52). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2017.
2. Wiznia DH, Maisano J, Kim CY, et al. The effect of insurance type on trauma patient access to psychiatric care under the Affordable Care Act. Gen Hosp Psychiatry. 2017;45:19-24.
3. Dorner SC, Jacobs DB, Sommers BD. Adequacy of outpatient specialty care access in marketplace plans under the Affordable Care Act. JAMA. 2015;314:1749-1750.
4. Beronio K, Glied S, Frank R. How the affordable care act and mental health parity and addiction equity act greatly expand coverage of behavioral health care. J Behav Health Serv Res. 2014;41:410-428.
5. Buck JA. The looming expansion and transformation of public substance abuse treatment under the Affordable Care Act. Health Aff (Millwood). 2011;30:1402-1410.
6. Barry CL, Goldman HH, Huskamp HA. Federal parity in the evolving mental health and addiction care landscape. Health Aff (Millwood). 2016;35:1009-1016.
7. Wen H, Cummings JR, Hockenberry JM, et al. State parity laws and access to treatment for substance use disorder in the United States: implications for federal parity legislation. JAMA Psychiatry. 2013;70:1355-1362.
8. Peterson E, Busch S. Achieving mental health and substance use disorder treatment parity: a quarter century of policy making and research. Annu Rev Public Health. 2018;39:421-435.
9. Barry CL, Huskamp HA. Moving beyond parity-mental health and addiction care under the ACA. New Engl J Med. 2011;365:973-975.
10. Mark TL, Yee T, Levit KR, et al. Insurance financing increased for mental health conditions but not for substance use disorders, 1986-2014. Health Aff (Millwood). 2016;35:958-965.
11. Busch SH, Meara E, Huskamp HA, et al. Characteristics of adults with substance use disorders expected to be eligible for Medicaid under the ACA. Psychiatr Serv. 2013;64:520-526.
12. Saloner B, Karthikeyan S. Changes in substance abuse treatment use among individuals with opioid use disorders in the United States, 2004-2013. JAMA. 2015;314:1515-1517.
13. Geissler KH, Lubin B, Ericson KMM. Access is not enough: characteristics of physicians who treat medicaid patients. Med Care. 2016;54:350-358.
14. Sommers BD, Kronick R. Measuring Medicaid physician participation rates and implications for policy. J Health Polit Policy Law. 2016;41:211-224.
15. Polsky D, Richards M, Basseyn S, et al. Appointment availability after increases in Medicaid payments for primary care. New Engl J Med. 2015;372:537-545.
16. Bishop TF, Press MJ, Keyhani S, et al. Acceptance of insurance by psychiatrists and the implications for access to mental health care. JAMA Psychiatry. 2014;71:176-181.
17. McGuire TG. Achieving mental health care parity might require changes in payments and competition. Health Aff (Millwood). 2016;35:1029-1035.
18. Busch SH, McGinty EE, Stuart EA, et al. Was federal parity associated with changes in out-of-network mental health care use and spending? BMC Health Serv Res. 2017;17:315.
19. Garfield RL, Lave JR, Donohue JM. Health reform and the scope of benefits for mental health and substance use disorder services. Psychiatr Serv. 2010;61:1081-1086.
20. Stuart EA, Barry CL, Donohue JM, et al. Effects of accountable care and payment reform on substance use disorder treatment: evidence from the initial 3 years of the alternative quality contract. Addiction. 2017;112:124-133.
21. Cummings JR, Wen H, Ko M, et al. Race/ethnicity and geographic access to Medicaid substance use disorder treatment facilities in the United States. JAMA Psychiatry. 2014;71:190-196.
22. Cummings JR, Wen H, Ko M, et al. Geography and the Medicaid mental health care infrastructure: implications for health care reform. JAMA Psychiatry. 2013;70:1084-1090.
23. Guerrero EG. Enhancing access and retention in substance abuse treatment: the role of Medicaid payment acceptance and cultural competence. Drug Alcohol Depend. 2013;132:555-561.
24. Andrews CM. The relationship of state Medicaid coverage to Medicaid acceptance among substance abuse providers in the United States. J Behav Health Serv Res. 2014;41:460-472.
25. Terry-McElrath YM, Chriqui JF, McBride DC. Factors related to Medicaid payment acceptance at outpatient substance abuse treatment programs. Health Serv Res. 2011;46:632-653.
26. Andrews CM, Grogan CM, Smith BT, et al. Medicaid benefits for addiction treatment expanded after implementation of the Affordable Care Act. Health Aff (Millwood). 2018;37:1216-1222.
27. Andrews CM, Grogan CM, Westlake MA, et al. Do benefits restrictions limit Medicaid acceptance in addiction treatment? Results from a national study. J Subst Abuse Treat. 2018;87:50-55.
28. Maclean J, Saloner B. Substance use treatment provider behavior and healthcare reform: evidence from Massachusetts. Health Econ. 2018;27:76-101.
29. Maclean JC, Saloner B. The effect of public insurance expansions on substance use disorder treatment: evidence from the Affordable Care Act. J Policy Anal Manage. 2019;38:366-393.
30. Saloner B, Akosa Antwi Y, Maclean J, et al. Access to health insurance and utilization of substance use disorder treatment: evidence from the affordable care act dependent coverage provision. Health Econ. 2018;27:50-75.
31. Maclean JC, Popovici I, Stern ER. Health insurance expansions and providers' behavior: evidence from substance-use- disorder treatment providers. J Law Econ. 2018;61:279-310.
32. Dave D, Mukerjee S. Mental health parity legislation, cost-sharing and substance-abuse treatment admissions. Health Econ. 2011;20:161-183.
33. McGinty EE, Busch SH, Stuart EA, et al. Federal parity law associated with increased probability of using out-of-network substance use disorder treatment services. Health Aff (Millwood). 2015;34:1331-1339.
34. Clark RE, Samnaliev M, McGovern MP. Impact of substance disorders on medical expenditures for medicaid beneficiaries with behavioral health disorders. Psychiatr Serv. 2009;60:35-42.
35. Center for Medicare and Medicaid Services. Medicaid and CHIP Managed Care Final Rule (CMS 2390-F): Strengthening the Consumer Experience. 2016. Available at: www.medicaid.gov/medicaid-chip-program-information/by-topics/delivery-systems/managed-care/downloads/strengthening-the-consumer-experience-fact-sheet.pdf. Accessed September 7, 2016.
36. Kaiser Family Foundation. Total Medicaid Managed Care Enrollment. 2018. Available at: www.kff.org/medicaid/state-indicator/total-medicaid-mc-enrollment/. Accessed January 20, 2018.
37. Substance Abuse and Mental Health Services Administration. National Survey of Substance Abuse Treatment Services (N-SSATS). 2002-2016. 2018. Available at: wwwdasis.samhsa.gov/dasis2/nssats.htm. Accessed March 23, 2018.
38. Edmond MB, Aletraris L, Roman PM, et al. The United States' Federal Parity Act and treatment of substance use disorders: administrators' familiarity and perceptions of impact. Int J Drug Policy. 2016;34:80-87.
39. Kaestner R, Garrett B, Chen J, et al. Effects of ACA Medicaid expansions on health insurance coverage and labor supply. J Policy Anal Manag. 2017;36:608-642.
40. Kaiser Family Foundation. Status of State Action on the Medicaid Expansion Decision. 2018. Available at: http://www.kff.org/health-reform...- ouverture dans une nouvelle fenêtre. Accessed January 23, 2018.
41. Zuckerman S, Skopec L, Epstein M. Medicaid Physician Fees After the ACA Primary Care Fee Bump. Washington, DC: Urban Institute Health Policy Center; 2017.
42. Norton S, Zuckerman S. Trends in Medicaid physician fees, 1993-1998. Health Aff (Millwood). 2000;19:222-232.
43. Zuckerman S, McFeeters J, Cunningham P, et al. Changes in medicaid physician fees, 1998-2003: implications for physician participation. Health Aff (Millwood). 2004;23(suppl Web Exclusives):W4-374-W4-384.
44. Zuckerman S, Williams AF, Stockley KE. Trends in Medicaid physician fees, 2003-2008. Health Aff (Millwood). 2009;28:w510-w519.
45. Zuckerman S, Goin D. How Much Will Medicaid Physicain Fees for Primary Care Rise in 2013? Evidence from a 2012 Survey of Medicaid Physician Fees. Washington, DC: Kaiser Family Foundation; 2012.
46. United States Department of Health and Human Services (US DHHS), Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS). Bridged-Race Population Estimates, United States July 1st resident population by state, county, age, sex, bridged-race, and Hispanic origin, on CDC WONDER On-line Database. 2019. Available at: https://www.cdc.gov/nchs/nvss/br...- ouverture dans une nouvelle fenêtre. Accessed February 23, 2019.
47. Bureau of Labor Statistics. Local Area Unemployment Statistics. 2019. Available at: www.bls.gov/lau/ex14tables.htm. Accessed February 5, 2019.
48. Substance Abuse and Mental Health Services Administration. Interactive NSDUH State Estimates. 2019. Available at: https://pdas.samhsa.gov/saes/sta...- ouverture dans une nouvelle fenêtre. Accessed February 8, 2019.
49. United States Census Bureau. Health Insurance Historical Tables-HIB Series. 2019. Available at: http://www.census.gov/data/table...- ouverture dans une nouvelle fenêtre. Accessed February 5, 2019.
50. United States Census Bureau. Health Insurance Historical Tables-HIC Series. 2019. Available at: http://www.census.gov/data/table...- ouverture dans une nouvelle fenêtre. Accessed February 5, 2019.
51. McCarty D, Gustafson DH, Wisdom JP, et al. The Network for the Improvement of Addiction Treatment (NIATx): enhancing access and retention. Drug Alcohol Depend. 2007;88:138-145.
52. Institute of Medicine Committee on Crossing the Quality Chasm: Adaptation to Mental Health and Addictive Disorders. Improving the Quality of Health Care for Mental and Substance-Use Conditions: Quality Chasm Series. Washington (DC): The National Academies Press; 2006.
53. Fields D, Roman PM. Total quality management and performance in substance abuse treatment centers. Health Serv Res. 2010;45(6 pt 1):1630-1649.
54. Eby LT, Burk H, Maher CP. How serious of a problem is staff turnover in substance abuse treatment? A longitudinal study of actual turnover. J Subst Abuse Treat. 2010;39:264-271.
55. Knight DK, Broome KM, Edwards JR, et al. Supervisory turnover in outpatient substance abuse treatment. J Behav Health Serv Res. 2011;38:80-90.
56. Molfenter TD. Addiction treatment centers' progress in preparing for health care reform. J Subst Abuse Treat. 2014;46:158-164.
57. Hartz SM, Pato CN, Medeiros H, et al. Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psychiatry. 2014;71:248-254.
58. Lev-Ran S, Imtiaz S, Rehm J, et al. Exploring the association between lifetime prevalence of mental illness and transition from substance use to substance use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC). Am J Addict. 2013;22:93-98.
59. Swendsen J, Conway KP, Degenhardt L, et al. Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction. 2010;105:1117-1128.
60. Han B, Compton WM, Jones CM, et al. Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003-2013. JAMA. 2015;314:1468-1478.
|
Language: | English.
|
Document Type: | Original Articles.
|
Journal Subset: | Clinical Medicine. Public Health.
|
ISSN: | 0025-7079
|
NLM Journal Code: | 0230027, lsm
|
DOI Number: | https://dx.doi.org/10.1097/MLR.0...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|